Clinical Trials in Portland

Showing 7821-7840 of 10,048 trials

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

NCT00948961

The main purpose of this study is to examine the safety and tolerability of CDX-1401 when given in combination with an immune stimulant (resiquimod) to patients with advanced cancers that are known to express the NY-ESO-1 protein.

Advanced Malignancies

Celldex Therapeutics70 participantsStarted Sep 2009

New Haven, Connecticut, United States • Miami Beach, Florida, United States • Detroit, Michigan, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

NCT00360555

This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.

Sexual Dysfunctions, Psychological

Sprout Pharmaceuticals, Inc1,584 participantsStarted Jul 2006

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +74 more locations

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

Find Trials by Condition in Portland

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Vitamin D to Prevent Autism in Newborn Siblings

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

A Performance Evaluation of the Enlite 3 Sensor

A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Ocriplasmin Research to Better Inform Treatment (ORBIT)

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

TBI-Prognosis Multicenter Prospective Study

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection